Excellence in the Study of Kidney Cancer
The Kidney Cancer Research Program at Stanford University is a forum to encourage multidisciplinary approaches to basic, pre-clinical, translational, and patient-oriented kidney cancer research. The Program includes a bi-monthly seminar to highlight the work of our growing group of Stanford faculty interested in kidney cancer research. The Program is designed to facilitate interactions, as well as to foster the development of new research efforts in the study of kidney cancer.
Kidney cancer (renal cell carcinoma) is one of the most commonly diagnosed cancers (6th in men and 8th in women) and is responsible for 3-5% of all new cancer diagnosis in the United States. The incidence of renal cell carcinoma has been steadily increasing for the past 40 years. Renal cell carcinoma represents a clinical challenge as it includes several distinct tumor types, including clear cell, papillary, chromophobe, collecting duct, and unclassified. Each subtype demonstrates unique clinical behavior and responds to different treatments. Given this heterogeneity, there is a need for innovative and collaborative research efforts to further our understanding of the disease.
Stanford Kidney Cancer Research Seminar
The Stanford Kidney Cancer Research Program presents a biweekly seminar series to bring together graduate students, post-doctoral fellows, and faculty from Stanford and the kidney cancer community. The Kidney Cancer Research Seminar Series occurs on the 2nd and 4th Wednesday from 12:00 to 1:00 PM in Grant S-289 and follows a work-in-progress format with active discussion among participants.